Psychemedics (NASDAQ:PMD) Shares Cross Above 200-Day Moving Average – Should You Sell?

Psychemedics Co. (NASDAQ:PMD) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.33 and traded as high as $2.35. Psychemedics shares last traded at $2.33, with a volume of 26,766 shares trading hands.

Psychemedics Stock Performance

The stock has a market capitalization of $13.73 million, a price-to-earnings ratio of -4.59 and a beta of 0.65. The stock’s 50 day moving average is $2.32 and its 200 day moving average is $2.33. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.01.

Psychemedics Company Profile

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol.